Market Overview:
The global bacterial pneumonia therapeutics market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of bacterial pneumonia, rising demand for novel antibiotics and vaccines, and growing number of mergers and acquisitions in the pharmaceutical industry. Based on type, the global bacterial pneumonia therapeutics market is segmented into antibiotics and vaccines. The antibiotics segment is further sub-segmented into beta-lactams, quinolones, tetracyclines, macrolides/lincosamides/streptogramins (MLS), aminoglycosides, glycopeptides, and other antibiotics. The vaccines segment is further sub-segmented into pneumococcal conjugate vaccine (PCV), Haemophilus influenzae type b (Hib) vaccine Hib/MenCYW135 vaccine,, meningococcal B (MenB) vaccine,, tetanus toxoid conjugate pneumococcal protein D (PPD) vaccine,, 13 valent pneumococcal polysaccharide conjugatevaccine(13vPPV). Based on application, the global bacterial pneumonia therapeutics market is divided into hospital pharmacies,, retail pharmacies,,,, mail order pharmacies,. Geographically speaking,. North America dominates the global bacterial pneumonia therapeutics market followed by Europe due to high prevalence of respiratory diseases in these regions.
Product Definition:
Bacterial pneumonia is an infection that affects the lungs. It is most often caused by bacteria, but can also be caused by viruses, fungi, or parasites. Symptoms include coughing, chest pain, shortness of breath, rapid breathing, and fever. Treatment includes antibiotics and hospitalization for those with a severe infection. Bacterial pneumonia is a serious illness that can lead to death in some cases.
Antibiotics:
Antibiotics Market Size, Share & Trends Analysis Report By Product (Penicillin, Cephalosporin), By Application (Bacterial Pneumonia), And Segment Forecasts, 2019 - 2025 -> The global antibiotics market size was valued at USD 20.5 billion in 2018 and is anticipated to expand at a CAGR of XX% during the forecast period. Growing prevalence of bacterial pneumonia is one of the major factors expected to drive growth.
Vaccines:
Vaccines are biological agents used to stimulate the body's immune system to act against specific disease-causing microorganisms. There are a number of vaccines available for bacterial pneumonia, depending on the type and location of the infection. Some of these include conjugate vaccines (Dukoral/HBIG), recombinant vaccine (RV), and toxoid vaccine.
Application Insights:
The hospital pharmacies segment held the largest share of 59.1% in 2017. This is attributed to factors such as presence of a large patient base with bacterial pneumonia and increasing number of hospitals and healthcare centers across the globe. Hospital-based pharmacists are engaged in filling prescriptions and providing medication management services for patients with BPCO, thus boosting market growth.
In addition, an increase in government initiatives to improve treatment outcomes is expected to boost product demand over the forecast period. For instance, according to a study published by NCBI in 2018, it was observed that patients diagnosed with BPCO were less likely than others to receive antibiotic treatment at an early stage owing to lack of awareness about this disease among healthcare professionals as well as family members outside hospitals which can be remedied through various public health programs supported by governments globally which will further fuel market growth over the coming years (Ref).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to favorable healthcare infrastructure, high disease prevalence, and increasing antibiotic-resistant bacteria. Moreover, rising government initiatives for promoting vaccination programs are expected to boost product demand in this region. For instance, the pneumococcal vaccine is offered as part of the National Pneumococcal Vaccination Program (NVP). The program was launched by CDC’s immunization division and it aims at reducing serious risks caused by these bacteria.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing target population base with high susceptibility toward bacterial infections.
Growth Factors:
- Increasing incidence of bacterial pneumonia across the globe
- Rising demand for better and more effective therapeutics for bacterial pneumonia
- Growing number of clinical trials for novel therapies for bacterial pneumonia
- increasing funding from government and private organizations for research on bacterial pneumonia therapies
- Emergence of new players in the market
Scope Of The Report
Report Attributes
Report Details
Report Title
Bacterial Pneumonia Therapeutics Market Research Report
By Type
Antibiotics, Vaccines
By Application
Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
By Companies
AstraZeneca, Nabriva Therapeutics, SetLance, Merck, Daiichi Sankyo Company, GlaxoSmithKline, Pfizer, Sanofi Pasteur
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
141
Number of Tables & Figures
99
Customization Available
Yes, the report can be customized as per your need.
Global Bacterial Pneumonia Therapeutics Market Report Segments:
The global Bacterial Pneumonia Therapeutics market is segmented on the basis of:
Types
Antibiotics, Vaccines
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Retail Pharmacies, Mail Order Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AstraZeneca
- Nabriva Therapeutics
- SetLance
- Merck
- Daiichi Sankyo Company
- GlaxoSmithKline
- Pfizer
- Sanofi Pasteur
Highlights of The Bacterial Pneumonia Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibiotics
- Vaccines
- By Application:
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bacterial Pneumonia Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bacterial pneumonia therapeutics are medications used to treat bacterial pneumonia. These medications help to kill the bacteria that is causing the infection, and they can also help to relieve symptoms of bacterial pneumonia.
Some of the key players operating in the bacterial pneumonia therapeutics market are AstraZeneca, Nabriva Therapeutics, SetLance, Merck, Daiichi Sankyo Company, GlaxoSmithKline, Pfizer, Sanofi Pasteur.
The bacterial pneumonia therapeutics market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Bacterial Pneumonia Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Bacterial Pneumonia Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Bacterial Pneumonia Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Bacterial Pneumonia Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Bacterial Pneumonia Therapeutics Market Size & Forecast, 2018-2028
4.5.1 Bacterial Pneumonia Therapeutics Market Size and Y-o-Y Growth
4.5.2 Bacterial Pneumonia Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Bacterial Pneumonia Therapeutics Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Bacterial Pneumonia Therapeutics Market Size Forecast by Type
5.2.1 Antibiotics
5.2.2 Vaccines
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Bacterial Pneumonia Therapeutics Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Bacterial Pneumonia Therapeutics Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Retail Pharmacies
6.2.3 Mail Order Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Bacterial Pneumonia Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Bacterial Pneumonia Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Bacterial Pneumonia Therapeutics Analysis and Forecast
9.1 Introduction
9.2 North America Bacterial Pneumonia Therapeutics Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Bacterial Pneumonia Therapeutics Market Size Forecast by Type
9.6.1 Antibiotics
9.6.2 Vaccines
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Bacterial Pneumonia Therapeutics Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Retail Pharmacies
9.10.3 Mail Order Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Bacterial Pneumonia Therapeutics Analysis and Forecast
10.1 Introduction
10.2 Europe Bacterial Pneumonia Therapeutics Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Bacterial Pneumonia Therapeutics Market Size Forecast by Type
10.6.1 Antibiotics
10.6.2 Vaccines
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Bacterial Pneumonia Therapeutics Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Retail Pharmacies
10.10.3 Mail Order Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Bacterial Pneumonia Therapeutics Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Bacterial Pneumonia Therapeutics Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Bacterial Pneumonia Therapeutics Market Size Forecast by Type
11.6.1 Antibiotics
11.6.2 Vaccines
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Bacterial Pneumonia Therapeutics Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Retail Pharmacies
11.10.3 Mail Order Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Bacterial Pneumonia Therapeutics Analysis and Forecast
12.1 Introduction
12.2 Latin America Bacterial Pneumonia Therapeutics Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Bacterial Pneumonia Therapeutics Market Size Forecast by Type
12.6.1 Antibiotics
12.6.2 Vaccines
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Bacterial Pneumonia Therapeutics Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Retail Pharmacies
12.10.3 Mail Order Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Bacterial Pneumonia Therapeutics Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Bacterial Pneumonia Therapeutics Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Bacterial Pneumonia Therapeutics Market Size Forecast by Type
13.6.1 Antibiotics
13.6.2 Vaccines
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Bacterial Pneumonia Therapeutics Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Retail Pharmacies
13.10.3 Mail Order Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Bacterial Pneumonia Therapeutics Market: Competitive Dashboard
14.2 Global Bacterial Pneumonia Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 AstraZeneca
14.3.2 Nabriva Therapeutics
14.3.3 SetLance
14.3.4 Merck
14.3.5 Daiichi Sankyo Company
14.3.6 GlaxoSmithKline
14.3.7 Pfizer
14.3.8 Sanofi Pasteur
